BPC-157 + GHK-Cu + TB-500

BPC-157 + GHK-Cu + TB-500: A three-component blend with a 10 + 50 + 10 mg composition.

What is it?

A three-component blend with a 10 + 50 + 10 mg composition.

How it is studied

It combines compounds associated with tissue signalling, copper-peptide biology, and thymosin-related research.

What the evidence says

Ingredient-level evidence is not evidence for this mixture. A clinical benefit has not been established here for the complete blend.

What remains uncertain

Similarly named blends can have different proportions or identities. Do not substitute findings from a 10 + 50 + 5 mg mixture. Copper-related considerations, compatibility, and stability remain separate research questions.

Sources & scope

Systematic review of musculoskeletal evidence (2025)

Maquart et al., experimental wound study (1993)

Thymosin beta-4 ophthalmic study

For in-vitro laboratory research only. Not for human or veterinary use.